Chemo plus radiation before surgery increases tumor response for rectal cancer, study suggests
Monday, September 26, 2011 - 16:30
in Health & Medicine
Rectal cancer patients who use a new combination of the chemotherapy, Capecitabine, together with five weeks of radiation (50 Gy) before surgery have an 88 percent chance of surviving the cancer three years after treatment, according to new research.